A selective role of NKG2D in inflammatory and autoimmune diseases

Clinical Immunology

Volumn 149, Issue 3 PB, 2013, Pages 432-439

  Guerra, Nadia ^a,b   Pestal, Kathleen ^a   Juarez, Tiffany ^a   Beck, Jennifer ^a   Tkach, Karen ^a   Wang, Lin ^a   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

EAE; Intestinal inflammation; NK cells; NKG2D; NOD; Type 1 diabetes

Indexed keywords

ANTIBODY; ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; NKG2D ANTIBODY; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE ENCEPHALITIS; AUTOIMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; FEMALE; HEPATITIS; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION;

EID: 84887200597     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.09.003     Document Type: Article

References (43)

1. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003, 3:781-790.
2. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 2010, 235:267-285.
3. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8 αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001, 2:255-260.
4. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21:357-366.
5. Eagle R.A., Trowsdale J. Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 2007, 7:737-744.
6. Salih H.R., Rammensee H.G., Steinle A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 2002, 169:4098-4102.
7. Groh V., Wu J., Yee C., Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T- cell activation. Nature 2002, 419:734-738.
8. Groh V., Bruhl A., El-Gabalawy H., Nelson J.L., Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9452-9457.
9. Andersson A.K., Sumariwalla P.F., McCann F.E., Amjadi P., Chang C., McNamee K., et al. Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis. Arthritis Rheum. 2011, 63:2617-2629.
10. Hue S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004, 21:367-377.
11. Allez M., Tieng V., Nakazawa A., Treton X., Pacault V., Dulphy N., et al. CD4+NKG2D+T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 2007, 132:2346-2358.
12. Kjellev S., Haase C., Lundsgaard D., Urso B., Tornehave D., Markholst H. Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice. Eυr. J. Immunol. 2007, 37:1397-1406.
13. Ito Y., Kanai T., Totsuka T., Okamoto R., Tsuchiya K., Nemoto Y., et al. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G199-G207.
14. Lu M., Xia B., Ge L., Li Y., Zhao J., Chen F., et al. Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients. Immunology 2008, 128:e230-e236.
15. Fernandez-Morera J.L., Rodriguez-Rodero S., Lahoz C., Tunon A., Astudillo A., Garcia-Suarez O., et al. Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis. Hum. Immunol. 2008, 69:235-240.
16. Petukhova L., Duvic M., Hordinsky M., Norris D., Price V., Shimomura Y., et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010, 466:113-117.
17. Ogasawara K., Hamerman J.A., Ehrlich L.R., Bour-Jordan H., Santamaria P., Bluestone J.A., et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004, 20:757-767.
18. Qin H., Lee I.F., Panagiotopoulos C., Wang X., Chu A.D., Utz P.J., et al. Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling. Diabetes 2011, 60:857-866.
19. Van Belle T.L., Ling E., Haase C., Bresson D., Urso B., von Herrath M.G. NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes. J. Autoimmun. 2013, 40:66-73.
20. Wortham B.W., Eppert B.L., Motz G.T., Flury J.L., Orozco-Levi M., Hoebe K., et al. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. J. Immunol. 2012, 188:4468-4475.
21. Xia M., Guerra N., Sukhova G.K., Yang K., Miller C.K., Shi G.P., et al. Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis. Circulation 2011, 124:2933-2943.
22. Zhou R., Wei H., Sun R., Zhang J., Tian Z. NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7512-7515.
23. Guerra N., Tan Y.X., Joncker N.T., Choy A., Gallardo F., Xiong N., et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008, 28:571-580.
24. Kim S., Iizuka K., Aguila H.L., Weissman I.L., Yokoyama W.M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2731-2736.
25. Katz J.D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993, 74:1089-1100.
26. Carnaud C., Gombert J., Donnars O., Garchon H., Herbelin A. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 2001, 166:2404-2411.
27. Luhder F., Katz J., Benoist C., Mathis D. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities. J. Exp. Med. 1998, 187:379-387.
28. Poirot L., Benoist C., Mathis D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8102-8107.
29. Ogasawara K., Hamerman J.A., Hsin H., Chikuma S., Bour-Jordan H., Chen T., et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003, 18:41-51.
30. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002, 17:19-29.
31. Zhou R., Wei H., Sun R., Tian Z. Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice. J. Immunol. 2007, 178:4548-4556.
32. Pedotti R., Mitchell D., Wedemeyer J., Karpuj M., Chabas D., Hattab E.M., et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2001, 2:216-222.
33. Matsumoto Y., Kohyama K., Aikawa Y., Shin T., Kawazoe Y., Suzuki Y., et al. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur. J. Immunol. 1998, 28:1681-1688.
34. Zhang B., Yamamura T., Kondo T., Fujiwara M., Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 1997, 186:1677-1687.
35. Winkler-Pickett R., Young H.A., Cherry J.M., Diehl J., Wine J., Back T., et al. In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses. J. Immunol. 2008, 180:4495-4506.
36. Kupz A., Scott T.A., Belz G.T., Andrews D.M., Greyer M., Lew A.M., et al. Contribution of Thy1+ NK cells to protective IFN-gamma production during Salmonella Typhimurium infections. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:2252-2257.
37. Holdenrieder S., Eichhorn P., Beuers U., Samtleben W., Stieber P., Nagel D., et al. Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism. Anticancer. Res. 2007, 27:2041-2045.
38. Markle J.G., Frank D.N., Mortin-Toth S., Robertson C.E., Feazel L.M., Rolle-Kampczyk U., et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013, 339:1084-1088.
39. Darlington P.J., Podjaski C., Horn K.E., Costantino S., Blain M., Saikali P., et al. Innate immune-mediated neuronal injury consequent to loss of astrocytes. J. Neuropathol. Exp. Neurol. 2008, 67:590-599.
40. Saikali P., Antel J.P., Newcombe J., Chen Z., Freedman M., Blain M., et al. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J. Neurosci. 2007, 27:1220-1228.
41. Bakker A.B., Hoek R.M., Cerwenka A., Blom B., Lucian L., McNeil T., et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 2000, 13:345-353.
42. Diefenbach A., Tomasello E., Lucas M., Jamieson A.M., Hsia J.K., Vivier E., et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 2002, 3:1142-1149.
43. Lanier L.L. DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev. 2009, 227:150-160.